Picodya
1 known investors
Picodya develops an in-vitro diagnostics (IVD) platform for near-patient syndromic testing that runs both molecular and immunoassay panels from bodily fluids such as blood, urine, saliva, and nasopharyngeal swabs. Its automated B-Matrix system uses microfluidic ("PicoFluidics") disposable cartridges and AI-driven image processing to run multiple patient samples in parallel for clinical and research settings.
AI & Machine LearningBiotechMedical Devices
Investors · 1
Frequently asked questions
- What does Picodya do?
- Picodya develops an in-vitro diagnostics (IVD) platform for near-patient syndromic testing that runs both molecular and immunoassay panels from bodily fluids such as blood, urine, saliva, and nasopharyngeal swabs. Its automated B-Matrix system uses microfluidic ("PicoFluidics") disposable cartridges and AI-driven image processing to run multiple patient samples in parallel for clinical and research settings.
- Who are Picodya's investors?
- Picodya's investors include SIBF (Southern Israel Bridging Fund) VC.